A spin-out company from Lancaster University that develops novel cell culture devices that enable the growth of human cell cultures in three dimensional form (3D), in laboratory conditions, that better replicate the micro-environments of living tissues. Revivocell technology aims to reduce the reliance on animal testing, improve the understanding of disease, and improve research in drug discovery.
